A surge in deals and financings had the industry abuzz heading into this year’s J.P Morgan Healthcare Conference. But some ...
The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...
The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...
Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies are expected to go public amid a ...
Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.
24/7 Wall St. on MSN
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
Aging-focused biotech companies share how they're advancing therapies to slow disease, extend lifespan, and transform medicine.
Oxford, major contract manufacturer to cell and gene therapy companies, has already rejected multiple, unsolicited ...
PARIS - French flavor and fragrance supplier Mane Group has acquired Belgian biotech company ChemoSensoryx Biosciences.
Tessera Therapeutics, a genetic medicine company, is laying off 90 employees as it refocuses on a new partnership. The post Somerville biotech company laying off 35% of workforce appeared first on ...
This Somerville biotech company is gearing up to lay off more than 80 employees in Massachusetts this year. Here's what we ...
The real estate investment trust sold off hundreds of millions of dollars worth of medical buildings to fund its latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results